62 results
Page 3 of 4
424B3
4wx xc3b17
25 Apr 23
Prospectus supplement
8:14am
6-K
EX-99.1
e2n8 dpmszai0
24 Apr 23
NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating
8:08am
POS AM
jbj9j3 zdv53
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
6-K
EX-99.1
l0390j6q44r
31 Mar 23
NewAmsterdam Pharma Reports Full Year 2022 Financial Results and Provides Corporate Update
8:36am
F-1
c3w 6nrztm5ljxy
19 Dec 22
Registration statement (foreign)
6:22pm
6-K
EX-99.1
wgn dmtkee
23 Nov 22
Current report (foreign)
4:36pm
6-K
EX-2.1
2pho1l
23 Nov 22
Current report (foreign)
4:36pm
424B3
vfexhgg dzxck614a
18 Oct 22
Prospectus supplement
4:41pm
F-4/A
gzt6jk5ixkgqlstrkm5
13 Oct 22
Registration of securities (foreign) (amended)
5:18pm
425
g07q bnjv
5 Oct 22
Business combination disclosure
4:16pm
F-4/A
92t6kssc22
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
CORRESP
whpahmo
3 Oct 22
Correspondence with SEC
12:00am
UPLOAD
xehcp4wdpy3y
27 Sep 22
Letter from SEC
12:00am
425
f75o8z
21 Sep 22
Business combination disclosure
8:31am
F-4/A
hpcvg6fl1zhmn72eyg7
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
425
voopu55
24 Aug 22
Business combination disclosure
5:04pm
425
81sqx2 fjj
24 Aug 22
Business combination disclosure
5:02pm
425
5rn wc0y1
11 Aug 22
Business combination disclosure
5:28pm
425
85zv0lov78v1d5
11 Aug 22
Business combination disclosure
4:30pm